Researchers at Mount Sinai launch a new AI platform to match more cancer patients with clinical trials, aiming to expand ...
Clinical Trials Arena on MSN
QPS adopts Oracle Argus to advance safety in clinical trials
The integration of Oracle Argus enables QPS to better capture, manage, and report adverse events for regulatory requirements.
Many people are surprised to learn that clinical trials aren't just for people who have run out of standard treatment options ...
Many clinical trials include a placebo group—participants who receive an inactive treatment—so researchers can compare ...
Clinical trials continue to be a driving force in ophthalmology, propelling the development of innovative treatments and ...
Clinical Trials Arena on MSN
Trialbee secures VHP investment to boost clinical trial recruitment
The funding will enable further international expansion, as well as development of the company’s Omnichannel partner ...
A new study suggests that the immune checkpoint inhibitor, durvalumab, may offer new treatment options for patients living ...
As clinical research evolves at an unprecedented pace, it’s important that physicians understand how emerging trends may ...
Researchers at the UCLA Health Jonsson Comprehensive Cancer Center have launched a clinical trial, called ANDROMEDA, to ...
As 2026 begins, a slate of high-stakes clinical readouts—from a pivotal study of Novartis’ cardiovascular candidate ...
GlobalData on MSN
BMS reports positive results in Phase III SCOUT-HCM trial for oHCM
The trial achieved its primary endpoint, showing a statistically significant reduction in Valsalva LVOT gradient at week 28.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results